Our leadership & board of directors
Management Team
-

Judy Van de Water, PhD
FOUNDER,
CHIEF SCIENCE ADVISOR -

Michael S. Paul, PhD
CHIEF EXECUTIVE OFFICER & PRESIDENT
-

E. Robert Wassman, MD
CHIEF MEDICAL OFFICER,
EVP OF CLINICAL AFFAIRS -

James N. Woody, MD, PhD
CHIEF SCIENCE OFFICER
-

Mags McInerney, PhD MBA
HEAD OF ASSAY DEVELOPMENT
Board of Directors
-

Gail Page
BOARD MEMBER
-

Vincent A. Forlenza, MBA
CHAIRMAN,
BOARD OF DIRECTORS -

Michael Kaufman
BOARD MEMBER
-

Craig Nemiroff
BOARD MEMBER
-

Michael S. Paul, PhD
CHIEF EXECUTIVE OFFICER & PRESIDENT
Board of Advisors
-

Marnin Kligfeld, PhD
CHAIRMAN,
ADVISORY BOARD -

Chuck Gardner, PgMP
ADVISORY BOARD MEMBER
Key Opinion Leaders
Developmental and Behavioral and General Pediatricians:
Dan Coury, MD
Developmental and Behavioral Pediatrician
Nationwide Children’s Director of Autism Treatment Network
Tom Frazier, PhD
Professor, Department of Psychology, John Carroll University
Former CSO, Autism Speaks
Former Dir., Center for Autism, Cleveland Clinic
Robin Hansen, MD
Developmental and Behavioral Pediatrician UC Davis / MIND Institute
David Traver, MD
General Pediatrician ASD practice in the San Francisco Bay Area
OB and IVF clinicians:
Mary Lake Polan, MD
Currently a Clinical Professor at Yale University School of Medicine.
Currently serves on the board of Quidel Corp and Motif Biosciences as well as on the boards of several privately held life sciences companies.
Managing Director of Golden Seeds, an angel investing group which invests in women led companies
Former Head, Stanford University IVF program
Sandra Carson, MD
Yale IVF Program Head
Former Chair ACOG Reproductive Medicine
Jan Rydfors, MD
Practicing OB/GYN with ASD families
Tony Manning, PhD
Experienced C-Level Pharma/Biotech Executive
Previous Chief Science Officer at Momenta Pharmaceuticals, Developed Nipocalimab biologic, best-in-class FcRn antagonist in maternal-fetal medicine, Successful exit via trade sale to J&J for $6.5 billion
Commercial Advisors
Kristy Consalvo
Head of Marketing
18+ years of diagnostic products and services experience with multiple companies including BD Biosciences, Boston Heart Diagnostics, CareDx, Aspire Women’s Health, and Pion Instruments.
Head of Marketing at Allergenis
Rich Minicus
Chief Financial Advisor
Director, Corporate Business Development, Becton, Dickinson & Co., Chief Investment Officer, BD Ventures; Pfizer Medical Technology Group; Merrill Lynch Venture Capital and Investment Banking; J.P. Morgan Corporate Loan Officer
Stan Lapidus
Experienced Serial Entrepreneur in Autism and Diagnostic Testing Markets
Former CEO, SynapDx (Gene Expression Dx Testing for ASD), Founder of Cytyc Corp. / Thin Prep Pap Smear (acquired by Hologic for $6.2 billion in 2017), Founding President and CEO of Exact Sciences / Cologuard ($10 billion market capitalization in 2025)
Jeff Knupp
Head of Sales & Payor Relations
+25 years managing multi-million-dollar operations and diagnostics sales teams, including at PerkinElmer; responsible for numerous successful product launches and strategic reimbursement programs in prenatal, cancer and autism spaces
Prev. Sales Dir. and Dir. Market Dev. Specialty Diagnostics PerkinElmer